Stay updated on AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Sign up to get notified when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.

Latest updates to the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History. The 'HHS Vulnerability Disclosure' link and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe record history shows a new revision entry v3.3.2 and removal of v3.2.0, which are metadata changes to the study's history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedThe notice about government funding lapse and NIH operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check67 days agoChange DetectedVersion 2 (2023-09-17) updated recruitment status and related study details. Version 3 (2025-03-04) updated recruitment status, study status, and contacts/locations.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded a prominent government-status notice and a version upgrade to v3.2.0; removed the previous version tag v3.1.0.SummaryDifference13%

- Check96 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.3%

Stay in the know with updates to AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.